Measurement of Residual Disease for improved oncology trial outcomes
Presentation from Precision: Lung Cancer Summit, July 2017
Genomic technologies that empower and enhance immuno-oncology trials
Using anatomic pathology for biomarker development in clinical trials can help predict and assess...
Small-Volume RNA-seq and Improved SMART-Seq® v4 Workflow
A critical component in the fight against cancer and optimizing treatment outcomes for patients
A roadmap for a successful biomarker strategy
What you should know for your clinical development program
Comprehensive in-house end-to-end anatomic pathology and adjunct molecular services
Unique global flow cytometry services implemented with customizable solutions are designed to meet...
Learn who we are, what we do, and how we impact customers through the lens of our vision, mission...
Presentation from PMWC - Duke University, May 2017